En-Ling Wu
Overview
Explore the profile of En-Ling Wu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
180
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Burns L, Premkumar A, Czapar A, Wu E, Hutchison A, Jamil O, et al.
NEJM Evid
. 2025 Jan;
4(2):EVIDmr2400398.
PMID: 39873543
AbstractMorning Report is a time-honored tradition where physicians-in-training present cases to their colleagues and clinical experts to collaboratively examine an interesting patient presentation. The Morning Report section seeks to carry...
2.
Sun F, Batra A, Dickson D, Li Y, Wu E
Muscle Nerve
. 2024 Jun;
70(2):290-292.
PMID: 38850117
No abstract available.
3.
Wu E, Christian B, Rivera A, Fabian E, Macha I, Aris E, et al.
J Antimicrob Chemother
. 2023 Nov;
79(1):36-45.
PMID: 37935111
Background: An enhanced understanding of renal outcomes in persons with chronic HBV, HIV, and HBV/HIV coinfection is needed to mitigate chronic kidney disease in regions where HBV and HIV are...
4.
Wu E, Osborn R, Bertram C, Moore W, Galvin S, Bolon M, et al.
Sex Transm Dis
. 2022 Dec;
50(3):172-174.
PMID: 36455293
In this case series of 20 ambulatory and hospitalized adult patients treated for monkeypox virus at a large academic medical center in Chicago, Illinois, tecovirimat use was reserved for those...
5.
Wu E, Al-Heeti O, Hoff B, Williams J, Krueger K, Santoiemma P, et al.
Open Forum Infect Dis
. 2022 Aug;
9(8):ofac392.
PMID: 35983263
A patient presenting with recurrent ventriculoperitoneal shunt infection was found to have growing from cerebrospinal fluid (CSF), which remained persistently positive. Therapeutic monitoring of clarithromycin, imipenem, and linezolid in CSF...
6.
Al-Heeti O, Wu E, Ison M, Saluja R, Ramsey G, Matkovic E, et al.
Clin Infect Dis
. 2022 Jul;
76(3):e1320-e1327.
PMID: 35883256
Background: Cache Valley virus (CVV) is a mosquito-borne virus that is a rare cause of disease in humans. In the fall of 2020, a patient developed encephalitis 6 weeks following...
7.
Wu E, Kumar R, Moore W, Hall G, Vysniauskaite I, Kim K, et al.
J Gen Intern Med
. 2022 Apr;
37(10):2505-2513.
PMID: 35469360
Background: Disparities in access to anti-SARS-CoV-2 monoclonal antibodies have not been well characterized. Objective: We sought to explore the impact of race/ethnicity as a social construct on monoclonal antibody delivery....
8.
Ren C, Wu E, Hartmann E, Zhao H
Environ Sci Technol
. 2021 Oct;
55(23):15831-15842.
PMID: 34615350
Antibiotic resistance is the principal mechanism of an evergrowing bacterial threat. Antibiotic residues in the environment are a major contributor to the spread of antibiotic resistance genes (ARGs). Subinhibitory concentrations...
9.
Kumar R, Wu E, Stosor V, Moore W, Achenbach C, Ison M, et al.
Clin Infect Dis
. 2021 May;
74(2):363-364.
PMID: 34015090
No abstract available.
10.
Kumar R, Wu E, Stosor V, Moore W, Achenbach C, Ison M, et al.
Clin Infect Dis
. 2021 Apr;
74(1):24-31.
PMID: 33846730
Background: Coronavirus disease 2019 (COVID-19) has strained healthcare systems with patient hospitalizations and deaths. Anti-spike monoclonal antibodies, including bamlanivimab, have demonstrated reduction in hospitalization rates in clinical trials, yet real-world...